Calibre What Science Can Do

This website contains promotional content about AstraZeneca Medications. This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.

Acute Coronary Syndrome Case Studies

Next generation P2Y12 inhibitors improve survival in acute coronary syndrome (ACS): An analysis from the British Cardiovascular Intervention Society database
Dr. Hussain Contractor

Dr. Hussain Contractor is a Consultant Interventional Cardiologist at Manchester University NHS Foundation Trust. He graduated his MBChB in 2001 with a Commendation from the University of Aberdeen and also graduated an Intercalated BSc in Molecular and Cell Biology (1st Class Hons) in 1999.  After completing his SHO training in Australia and Bristol, Dr Contractor trained as an interventional cardiologist in Manchester.  Completing a DPhil in 2012 at the University of Oxford in the field of ischemia reperfusion injury and cardioprotective strategies, he has published widely in this field and remains active in cardiology research.  In 2015 Dr Contractor gained the highly prestigious Boston Scientific Interventional Fellowship to Vancouver Island, Canada, where he completed his training.  He has been a Consultant Interventional Cardiologist at Wythenshawe Hospital since 2016 where he specialises in complex angioplasty and chronic total occlusions. He has a strong interest in strategies to optimise cardiac secondary preventive strategies and has led efforts in Greater Manchester to establish community based clinics for long term secondary prevention.

Prolonged Dual Anti-Platelet Treatment following Percutaneous Coronary Intervention for ACS
Dr. Ian B. A. Menown